Kamal Adeela
SEC insider (Form 3/4/5 filer). CIK 0002153988. Chief Scientific Officer at Actinium Pharmaceuticals, Inc. (ATNM). 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. Located in NEW YORK, NY.
Companies Kamal Adeela has filed insider reports for
- Actinium Pharmaceuticals, Inc. (ATNM): Officer, Chief Scientific Officer
Kamal Adeela
CIK: 0002153988
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ATNM
Actinium Pharmaceuticals, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions